CClinicalTrials.gg
CompletedNCT06813287Updated Feb 6, 2025

Brain Monitoring, tDCS and Robotic Training in SCI

A Phase 2 interventional study of Electroencephalography (EEG) and Upper extremity robot in Spinal Cord Injuries, sponsored by Kathleen Friel. Completed at 1 site in United States. Open to participants aged 16 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-02-06.

Sponsored by Kathleen Friel · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years 6 months after the study started (first participant enrolled Nov 2012, registered May 2018).
Phase
Phase 2
Study type
Interventional
Enrollment
17
Allocation
Randomized
Ages
16 Years to 65 Years
Sex
All
01

Study summary

To explore the neurophysiological and electroencephalography (EEG) changes that one single session of tDCS and robotics has in the SCI population (Study 1); and to investigate upper limb motor recovery in chronic tetraplegia SCI patients, comparing two rehabilitation strategies: real or sham tDCS combined with upper-limb robotic therapy (Study 2), as well as to characterize the neurophysiological (TMS) and brain signaling (EEG) profile of patients and specific muscles that respond to the combination of neuromodulation and robotic motor training.

Read the detailed description

Current training interventions for rehabilitating patients with SCI are designed to provide the greatest possible restoration of function in the shortest possible time. One of the major deficits in our current approach to applying therapy is that we have little ability to predict which patients are most likely to respond to therapy or which muscle groups are most amenable to improvement. Transcranial magnetic stimulation (TMS) is a noninvasive method to excite or inhibit neurons in the brain or the spinal cord. Numerous studies have been using this technique to map connections from the motor cortex via the spinal cord to peripheral muscles; and as a therapeutic tool to promote useful plasticity.

The significance of the present study lies in the potential of intensive upper limb motor training with a novel robotic device, in conjunction with transcranial direct current stimulation (tDCS) over the contralateral motor cortex, may enhance neural recovery and upper limb function in patients with tetraplegia.

The robotic training devices represent the most sophisticated interactive rehabilitation systems available on the current market; they are additionally appealing for their ability to quantify various aspects of movement, and they appear to be particularly powerful way to promote functional recovery. Furthermore, robotic devices can be used in collection of quantitative data from the patients, which can be interpreted to analyze their rate of progress. Rehabilitation robots are capable of providing important components of motor skill learning and muscle training: individually prescribed intensity, repetition, and performance feedback. Furthermore, they are a novel and reliable method of assessing voluntary motor control. Our center has extensive experience in the use of rehabilitation robotics in the assessment and training of voluntary motor control in SCI patients, as well as other neurological disorders. From the investigator's previous experience using robotic therapy in SCI patients they can predict that some patients (approximately 10%) will show direct benefits from the interactive robot training.

The use of neuromodulatory techniques (TMS, tDCS) has been used for the last 2 decades in neurorehabilitation with the aim of enhance motor recovery when paired with activity dependent plasticity (training). In this proposal the investigator's will be using a new tDCS device, StarStim® - a wireless multichannel device that allows EEG recording as well as real or sham tDCS stimulation.

The purpose of this study is: To explore the neurophysiological and electroencephalography (EEG) changes that one single session of tDCS and robotics has in the SCI population (Study 1); and to investigate upper limb motor recovery in chronic tetraplegia SCI patients, comparing two rehabilitation strategies: real or sham tDCS combined with upper-limb robotic therapy (Study 2), as well as to characterize the neurophysiological (TMS) and brain signaling (EEG) profile of patients and specific muscles that respond to the combination of neuromodulation and robotic motor training.

Study 1, Objective: To evaluate changes in cortical neurophysiological and biological brain signaling after a single session of tDCS. The TMS responses of the upper limb muscles with lack of voluntary motor control will be assessed prior and after 20 min of tDCS intervention. Additionally, the investigators will record EEG activity before, during and after the intervention.

Study 2, Objective: To explore the accumulative effects of 2 weeks of tDCS + Robotic training in cortical excitability and brain signaling. In addition, the investigators will investigate whether the intensive robotic training in conjunction with tDCS over the contralateral motor cortex area will enhance neural recovery and upper limb function in patients with tetraplegia.

The investigators will compare two different brain stimulation protocols to assess the enhancement of the motor performance of those muscles that lack motor control, comparing the effects of 2-weeks intensive hand-robotic training with real or sham tDCS.

The investigators hypothesize that the patients who undergo real tDCS in conjunction with prolonged intense robotic training will achieve greater improvements in motor function and sensation compared to their counterparts who are in the sham control group.

02

Conditions studied

  • Spinal Cord Injuries
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 17 is below the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Kathleen Friel is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Level of injury C5 to T1
  • Chronic SCI > 6 months
  • Tetraplegic with some degree of motor dysfunction in the upper limb
  • Motor Incomplete/Complete
  • Medically stable

Exclusion criteria

Exclusion Criteria:

  • \< 6 month after injury
  • History of head trauma and/or cognitive deficit
  • History of stroke, seizures or other intracranial disease
  • Medically unstable
  • Concomitant neurological disorder
  • Pre-existing medical conditions interfering with unrestricted movement of the hand/arm (e.g. osteoarthritis, injury to the joints)
  • Inability to provide informed consent
  • Contraindications for non-invasive brain stimulation (NIBS) techniques (TMS \& tDCS)- see below.

Non-Invasive Brain Stimulation Contraindications

  • Surgically implanted foreign bodies such as a pacemaker, implanted medication pump, metal plate in the skull
  • Metal inside the skull (other than dental appliances or fillings) that may pose a physical hazard during magnetic stimulation.
  • No skin condition
  • Any significant medical or psychiatric illness
  • History of epilepsy
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
17 participants (actual)

Study arms

  • Experimental
    tDCS & EEG

    20 minutes of real anodal tDCS of cortical neurophysiology and EEG responses in chronic spinal cord injury patients.

    Diagnostic Test: Electroencephalography (EEG)

  • Sham comparator
    Sham tDCS

    2 weeks (5x per week) of upper limb robotic training in conjunction with sham tDCS.

    Device: Upper extremity robot

  • Experimental
    Active tDCS

    2 weeks (5x per week) of upper limb robotic training in conjunction with active tDCS.

    Device: Upper extremity robot

Interventions

  • Diagnostic testElectroencephalography (EEG)

    Recording of electrical activity in the brain

  • DeviceUpper extremity robot

    Used for training and objective assessment (kinematics)

06

What researchers measure

Primary outcomes

  1. Motor Threshold

    The necessary stimulator output to evoke a response in the target muscle

    Time frame: Change in motor threshold from baseline to immediately post-intervention. This measure will also be repeated at a 1 month follow up evaluation.

  2. Action Research Arm Test

    Assessment of upper extremity motor improvements

    Time frame: Baseline, immediately after intervention.

  3. Amplitude of Response

    The size of the wave form (response) generated during motor threshold determination.

    Time frame: Change in amplitude from baseline to immediately post-intervention. This measure will also be repeated at a 1 month follow up evaluation.

Secondary outcomes

  1. Transcranial magnetic stimulation mapping

    Method of determining a specific muscle's spatial representation in the cortex.

    Time frame: Baseline, immediately after intervention, and 1 month follow up

  2. Electroencephalography (EEG) Recording

    Assessment of electrical activity in the brain over a period of time, as determined non-invasively through electrodes placed on the head.

    Time frame: Baseline, immediately after intervention, and 1 month follow up

  3. Muscle Strength Evaluation

    Maximum voluntary contraction of the studied upper extremity muscle

    Time frame: Baseline, immediately after intervention, and 1 month follow up

  4. Upper Extremity Motor Score (UEMS)

    Measure of upper extremity strength

    Time frame: Baseline, immediately after intervention

  5. Spinal Cord Independence Measure (SCIM III)

    Measure of functional independence in activities of daily living

    Time frame: Baseline, immediately after intervention

  6. Visual Analogue Scale

    Used as a self-report of pain

    Time frame: Baseline, immediately after intervention

  7. Quadriplegia Index of Function (QIF)

    Quality of life scale

    Time frame: Baseline, immediately after intervention

  8. Jebsen-Taylor Hand Function Test

    Assessment of fine motor skills

    Time frame: Baseline, immediately after intervention

  9. Motor Evoked Potential Facilitation

    Method of assessing a nerves response to an external stimuli (transcranial magnetic stimulation)

    Time frame: Baseline, immediately after intervention, and 1 month follow up

07

Study locations

1 site
  • Burke Medical Research Institute
    White Plains, New York 10605, United States
08

References and documents

Publications

  • Barbeau H, Nadeau S, Garneau C. Physical determinants, emerging concepts, and training approaches in gait of individuals with spinal cord injury. J Neurotrauma. 2006 Mar-Apr;23(3-4):571-85. doi: 10.1089/neu.2006.23.571. PubMed 16629638 ↗
  • Behrman AL, Harkema SJ. Physical rehabilitation as an agent for recovery after spinal cord injury. Phys Med Rehabil Clin N Am. 2007 May;18(2):183-202, v. doi: 10.1016/j.pmr.2007.02.002. PubMed 17543768 ↗
  • Krebs HI, Volpe B, Hogan N. A working model of stroke recovery from rehabilitation robotics practitioners. J Neuroeng Rehabil. 2009 Feb 25;6:6. doi: 10.1186/1743-0003-6-6. PubMed 19243615 ↗
  • Spooren AI, Janssen-Potten YJ, Kerckhofs E, Seelen HA. Outcome of motor training programmes on arm and hand functioning in patients with cervical spinal cord injury according to different levels of the ICF: a systematic review. J Rehabil Med. 2009 Jun;41(7):497-505. doi: 10.2340/16501977-0387. PubMed 19543659 ↗
  • Wirth B, Van Hedel HJ, Curt A. Changes in corticospinal function and ankle motor control during recovery from incomplete spinal cord injury. J Neurotrauma. 2008 May;25(5):467-78. doi: 10.1089/neu.2007.0472. PubMed 18419251 ↗
  • Yozbatiran N, Berliner J, O'Malley MK, Pehlivan AU, Kadivar Z, Boake C, Francisco GE. Robotic training and clinical assessment of upper extremity movements after spinal cord injury: a single case report. J Rehabil Med. 2012 Feb;44(2):186-8. doi: 10.2340/16501977-0924. PubMed 22334347 ↗

Individual participant data

Plan to share: No — There is no plan to make individual participant data available to other researchers at this time.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06813287
Lead sponsor
Kathleen Friel
Responsible party
Kathleen Friel (Lab Director, Clinical Laboratory for Early Brain Injury Recovery, Burke Medical Research Institute) — Sponsor-investigator
First posted
Feb 6, 2025
Start date
Nov 1, 2012
Primary completion
Dec 31, 2014
Completion
Jun 27, 2018
Last update
Feb 6, 2025

Study contacts

Mar Cortes, MD
principal investigator · Mt Sinai School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion